1.
Minerva Med
; 77(13): 503-4, 1986 Mar 31.
Article
in Italian
| MEDLINE
| ID: mdl-2422605
Subject(s)
Adenocarcinoma/diagnosis , Prostatic Neoplasms/diagnosis , Acid Phosphatase/blood , Adenocarcinoma/pathology , Aged , Antigens, Neoplasm/analysis , Calculi/diagnosis , Clinical Enzyme Tests , Evaluation Studies as Topic , Female , Humans , Male , Middle Aged , Neoplasm Staging , Prostate/enzymology , Prostate-Specific Antigen , Prostatic Hyperplasia/diagnosis , Prostatic Neoplasms/pathology , Time Factors
2.
Hepatogastroenterology
; 31(3): 123-4, 1984 Jun.
Article
in English
| MEDLINE
| ID: mdl-6469200
ABSTRACT
One hundred and seventy-one consecutive patients with HBsAg+ve CLD were investigated in order to assess whether they were actively replicating the hepatitis B virus, and therefore eligible for antiviral therapy. Our results show that only 5.8% of patients were actively replicating B virus and therefore antiviral therapy, when available, could be used only for a small subgroup of patients suffering from CLD due to hepatitis B virus chronic infection.
